Aptamer-Modified Temperature-Sensitive Liposomal Contrast Agent for Magnetic Resonance Imaging

Biomacromolecules. 2015 Sep 14;16(9):2618-23. doi: 10.1021/acs.biomac.5b00250. Epub 2015 Aug 7.

Abstract

A novel aptamer modified thermosensitive liposome was designed as an efficient magnetic resonance imaging probe. In this paper, Gd-DTPA was encapsulated into an optimized thermosensitive liposome (TSL) formulation, followed by conjugation with AS1411 for specific targeting against tumor cells that overexpress nucleolin receptors. The resulting liposomes were extensively characterized in vitro as a contrast agent. As-prepared TSLs-AS1411 had a diameter about 136.1 nm. No obvious cytotoxicity was observed from MTT assay, which illustrated that the liposomes exhibited excellent biocompatibility. Compared to the control incubation at 37 °C, the liposomes modified with AS1411 exhibited much higher T1 relaxivity in MCF-7 cells incubated at 42 °C. These data indicate that the Gd-encapsulated TSLs-AS1411 may be a promising tool in early cancer diagnosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Contrast Media* / chemistry
  • Contrast Media* / pharmacology
  • Drug Delivery Systems / methods*
  • Gadolinium DTPA* / chemistry
  • Gadolinium DTPA* / pharmacology
  • Humans
  • Liposomes
  • MCF-7 Cells
  • Materials Testing*
  • Neoplasm Proteins / metabolism*
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / metabolism
  • Peptides / metabolism*
  • Radiography
  • SELEX Aptamer Technique

Substances

  • Contrast Media
  • Liposomes
  • Neoplasm Proteins
  • Peptides
  • nucleolin binding peptide
  • Gadolinium DTPA